Paper28294492
High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.
Socías ME and 6 others. HIV Med, 2017. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs. Papers, record 28294492. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28294492
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Coinfection | Major topic |
| HIV Infections | Major topic |
| Hepatitis C | Major topic |
| Substance-Related Disorders | Major topic |
| Adult | |
| Canada | |
| Female | |
| Humans | |
| Male | |
| Patient Compliance | |
| Prevalence | |
| Prospective Studies | |
| Treatment Outcome |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DA021525 | NIDA NIH HHS | United States | R01DA021525 | PubMed and NIH | NIH RePORTER |
| R01 DA036307 | NIDA NIH HHS | United States | R01DA036307 | PubMed and NIH | NIH RePORTER |
| R25 DA037756 | NIDA NIH HHS | United States | R25DA037756 | PubMed and NIH | NIH RePORTER |
| U01 DA021525 | NIDA NIH HHS | United States | R01DA021525 | PubMed and NIH | NIH RePORTER |
| U01DA021525 | NIH | NIH RePORTER |
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15768339 | Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. | Clin Infect Dis | 2005 | https://conductscience.org/library/papers/15768339 | PubMed |
| 2 | 23884064 | Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23884064 | PubMed |
| 3 | 26922272 | Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. | Lancet Infect Dis | 2016 | https://conductscience.org/library/papers/26922272 | PubMed |
| 4 | 9707146 | Barriers to use of free antiretroviral therapy in injection drug users. | JAMA | 1998 | https://conductscience.org/library/papers/9707146 | PubMed |
| 5 | 25996567 | Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study. | J Viral Hepat | 2015 | https://conductscience.org/library/papers/25996567 | PubMed |
| 6 | 23884071 | Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23884071 | PubMed |
| 7 | 15768340 | Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. | Clin Infect Dis | 2005 | https://conductscience.org/library/papers/15768340 | PubMed |
| 8 | 18165889 | Limited uptake of hepatitis C treatment among injection drug users. | J Community Health | 2008 | https://conductscience.org/library/papers/18165889 | PubMed |
| 9 | 25042607 | Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada. | Hepatology | 2014 | https://conductscience.org/library/papers/25042607 | PubMed |
| 10 | 23223596 | Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23223596 | PubMed |
| 11 | 8651235 | Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. | Am J Epidemiol | 1996 | https://conductscience.org/library/papers/8651235 | PubMed |
| 12 | 23205675 | Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers. | J Viral Hepat | 2012 | https://conductscience.org/library/papers/23205675 | PubMed |
| 13 | 23429381 | Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23429381 | PubMed |
| 14 | 24820257 | Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance. | J Addict Med | 2014 | https://conductscience.org/library/papers/24820257 | PubMed |
| 15 | 23391612 | The effect of stimulant use on antiviral treatment in an integrated hepatitis clinic. | Gen Hosp Psychiatry | 2013 | https://conductscience.org/library/papers/23391612 | PubMed |
| 16 | 26248117 | Epidemiology of hepatitis C virus in HIV-infected patients. | Curr Opin HIV AIDS | 2015 | https://conductscience.org/library/papers/26248117 | PubMed |
| 17 | 21499577 | Physicians' attitudes and practice toward treating injection drug users with hepatitis C: results from a national specialist survey in Canada. | Can J Gastroenterol | 2011 | https://conductscience.org/library/papers/21499577 | PubMed |
| 18 | 26077144 | Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. | Int J Drug Policy | 2015 | https://conductscience.org/library/papers/26077144 | PubMed |
| 19 | 10405858 | The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities. | Int J Epidemiol | 1999 | https://conductscience.org/library/papers/10405858 | PubMed |
| 20 | 24331294 | EASL Clinical Practice Guidelines: management of hepatitis C virus infection. | J Hepatol | 2014 | https://conductscience.org/library/papers/24331294 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38487594 | Hepatitis C Virus Infection and Hospital-Related Outcomes: A Systematic Review. | Can J Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/38487594 | PubMed |
| 37280588 | Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study. | Int J Equity Health | 2023 | https://conductscience.org/library/papers/37280588 | PubMed |
| 35893702 | Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic. | Viruses | 2022 | https://conductscience.org/library/papers/35893702 | PubMed |
| 34556508 | Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review. | BMJ Open | 2021 | https://conductscience.org/library/papers/34556508 | PubMed |
| 33902968 | "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs. | Int J Drug Policy | 2021 | https://conductscience.org/library/papers/33902968 | PubMed |
| 33740984 | "I want to get better, but…": identifying the perceptions and experiences of people who inject drugs with respect to evolving hepatitis C virus treatments. | Int J Equity Health | 2021 | https://conductscience.org/library/papers/33740984 | PubMed |
| 29679811 | Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India. | Int J Drug Policy | 2018 | https://conductscience.org/library/papers/29679811 | PubMed |
| 29630030 | HIV Serostatus and Having Access to a Physician for Regular Hepatitis C Virus Care Among People Who Inject Drugs. | J Acquir Immune Defic Syndr | 2018 | https://conductscience.org/library/papers/29630030 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| MLC1 | 23209 | PubTator's text mining | https://conductscience.org/library/genes/23209 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28294492
GET https://conductscience.org/api/papers/v1/28294492/references?page=2